Sponsored by Kaneka
Developing robust and scalable purification processes for monoclonal antibodies (mAbs) can save time and money. KANEKA’s protein A chromatography resin, KANEKA KanCapA™, offers the required high-performance characteristics to develop platform purification processes for mAbs: high binding capacity, high alkaline stability, good elution profiles, low nonspecific binding, and robustness in column packing. Here we provide purification data of five different mAbs (two humanized IgG1s, two humanized IgG2s, and a chimeric IgG1) using KANEKA KanCapA™. The Chinese hamster ovary (CHO) cell culture supernatants were kindly provided to us by our customer.
Read the full text of this application note in the PDF (Login required).
You May Also Like
